Delivery Order HHSN271201600006I-75N95018F00005
Award Date
5/25/18
Potential Completion Date
8/24/19
Potential Value
$1.8M
Federal Agency
National Institute on Drug Abuse
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to SRI International, a non-profit research institute, for a suite of GLP toxicology studies under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract. The contract has a potential value of $2,149,530.00 and a completion date of May 31, 2021. It is not designated as a set-aside...
This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Southern Research Institute, a non-profit organization. The order is for $414,199.00 and is part of the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. The work will support management and operations for PTTP, which focuses on drug discovery and development, including for emerging infectious diseases,...
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This is a $7,323,160.93 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services (HHS). The contract is for continuous rodent and non-rodent pharmacokinetic assessments under the Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ contract. The prime contractor is SRI International, a large non-profit research and development institute that frequently partners...
This is a cost-plus-fixed-fee delivery order task order awarded by the Department of Health and Human Services' National Institute on Drug Abuse (NIDA) to nonprofit research institute SRI International. The contract, valued at $479,933.60, is for toxicological evaluations of potential medications over a period of performance from September 7, 2018 to September 6, 2023. SRI International has extensive experience providing research, engineering, and technical services to federal agencies such as...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for $403,254.01 and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract is for "Pharmacokinetics and Toxicology Studies - Buckpitt LDT" and is a Cost Plus Fixed Fee delivery order. The contract does not have a set-aside designation. SRI International is...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to SRI International, a non-profit research and development organization. The contract is an administrative task order under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery vehicle (IDV). The total ceiling value of this award is $106,072.00, and the period of performance is from September 13, 2015 to September 12, 2016. The contract is a...
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to the non-profit research institute SRI International. The contract is for a "Dog Dose Range Finding (DRF) Toxicity Study - BUCKPITT - LDT-EC5026" with a potential value of $179,557.00. The contract is part of the Pharmacology and Toxicology for Therapeutics Program (PTTP) and the place of performance is West Menlo Park,...
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to SRI International, a large non-profit research and development institute. The contract, valued at $1,726,546.26, is for conducting safety and toxicology studies on cystine, a chemical compound, as part of NIDA's Toxicological Evaluation of Novel Ligands Program. The contract is a cost-plus-fixed-fee type and does not have a small business set-aside....
This federal contract award was issued by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse to SRI International, a non-profit research and development institute, for the Pharmacology and Toxicology for Therapeutics Program (PTTP). The $2,363,694.00 cost-plus-fixed-fee contract is a delivery order under a larger IDIQ (Indefinite Delivery/Indefinite Quantity) vehicle. The contract does not have a set-aside designation. SRI International...